434 related articles for article (PubMed ID: 36124721)
61. Impact of pharmaceutical care interventions on glycemic control and other health-related clinical outcomes in patients with type 2 diabetes: Randomized controlled trial.
Wishah RA; Al-Khawaldeh OA; Albsoul AM
Diabetes Metab Syndr; 2015; 9(4):271-6. PubMed ID: 25301007
[TBL] [Abstract][Full Text] [Related]
62. Improvement of glycemic control in type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials.
Monami M; Candido R; Pintaudi B; Targher G; Mannucci E;
Nutr Metab Cardiovasc Dis; 2021 Aug; 31(9):2539-2546. PubMed ID: 34158243
[TBL] [Abstract][Full Text] [Related]
63. Adherence to the American Diabetes Association's Glycemic Goals in the Treatment of Diabetes Among Older Americans, 2001-2018.
Le P; Ayers G; Misra-Hebert AD; Herzig SJ; Herman WH; Shaker VA; Rothberg MB
Diabetes Care; 2022 May; 45(5):1107-1115. PubMed ID: 35076695
[TBL] [Abstract][Full Text] [Related]
64. HbA1c overtesting and overtreatment among US adults with controlled type 2 diabetes, 2001-13: observational population based study.
McCoy RG; Van Houten HK; Ross JS; Montori VM; Shah ND
BMJ; 2015 Dec; 351():h6138. PubMed ID: 26646052
[TBL] [Abstract][Full Text] [Related]
65. A Japanese Study Assessing Glycemic Control with Use of IDegAsp Co-formulation in Patients with Type 2 Diabetes in Clinical Practice: The JAGUAR Study.
Kaneko S; da Rocha Fernandes JD; Yamamoto Y; Langer J; Faurby M
Adv Ther; 2021 Mar; 38(3):1638-1649. PubMed ID: 33560496
[TBL] [Abstract][Full Text] [Related]
66. Implications of cognitive and daily living capabilities on early type 2 diabetes management: a preliminary case-control study.
Mahmoudi R; Kamari F; Naghdi Sadeh R; Naseri A; Sadra V
Eur J Med Res; 2024 Jun; 29(1):337. PubMed ID: 38890763
[TBL] [Abstract][Full Text] [Related]
67. Liberal Glycemic Control in Critically Ill Patients With Type 2 Diabetes: An Exploratory Study.
Kar P; Plummer MP; Bellomo R; Jenkins AJ; Januszewski AS; Chapman MJ; Jones KL; Horowitz M; Deane AM
Crit Care Med; 2016 Sep; 44(9):1695-703. PubMed ID: 27315191
[TBL] [Abstract][Full Text] [Related]
68. Risk Factors for Nocturnal Hypoglycemia in Insulin-treated Patients With Type 2 Diabetes: A Secondary Analysis of Observational Data Derived From an Integrated Clinical Trial Database.
Bae JP; Duan R; Fu H; Hoogwerf BJ
Clin Ther; 2017 Sep; 39(9):1790-1798.e7. PubMed ID: 28781218
[TBL] [Abstract][Full Text] [Related]
69. Unrecognized hypo- and hyperglycemia in well-controlled patients with type 2 diabetes mellitus: the results of continuous glucose monitoring.
Hay LC; Wilmshurst EG; Fulcher G
Diabetes Technol Ther; 2003; 5(1):19-26. PubMed ID: 12725703
[TBL] [Abstract][Full Text] [Related]
70. Efficacy and safety of linagliptin in subjects with long-standing type 2 diabetes mellitus (>10 years): evidence from pooled data of randomized, double-blind, placebo-controlled, phase III trials.
Lajara R; Aguilar R; Hehnke U; Woerle HJ; von Eynatten M
Clin Ther; 2014 Nov; 36(11):1595-605. PubMed ID: 25236917
[TBL] [Abstract][Full Text] [Related]
71. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.
Laffel LM; Kanapka LG; Beck RW; Bergamo K; Clements MA; Criego A; DeSalvo DJ; Goland R; Hood K; Liljenquist D; Messer LH; Monzavi R; Mouse TJ; Prahalad P; Sherr J; Simmons JH; Wadwa RP; Weinstock RS; Willi SM; Miller KM; ;
JAMA; 2020 Jun; 323(23):2388-2396. PubMed ID: 32543683
[TBL] [Abstract][Full Text] [Related]
72. New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3).
Bolli GB; Riddle MC; Bergenstal RM; Ziemen M; Sestakauskas K; Goyeau H; Home PD;
Diabetes Obes Metab; 2015 Apr; 17(4):386-94. PubMed ID: 25641260
[TBL] [Abstract][Full Text] [Related]
73. HbA1c and risk of severe hypoglycemia in type 2 diabetes: the Diabetes and Aging Study.
Lipska KJ; Warton EM; Huang ES; Moffet HH; Inzucchi SE; Krumholz HM; Karter AJ
Diabetes Care; 2013 Nov; 36(11):3535-42. PubMed ID: 23900589
[TBL] [Abstract][Full Text] [Related]
74. Concordance the hemoglobin glycation index with glycation gap using glycated albumin in patients with type 2 diabetes.
Kim MK; Jeong JS; Kwon HS; Baek KH; Song KH
J Diabetes Complications; 2017 Jul; 31(7):1127-1131. PubMed ID: 28487124
[TBL] [Abstract][Full Text] [Related]
75. Future glycemic control of children diagnosed with type 1 diabetes mellitus at toddler and preschool/school age.
Aeppli TRJ; Mahler FL; Konrad D
J Pediatr Endocrinol Metab; 2019 Sep; 32(9):929-933. PubMed ID: 31323008
[TBL] [Abstract][Full Text] [Related]
76. Glycemic control and high-density lipoprotein characteristics in adolescents with type 1 diabetes.
Medina-Bravo P; Medina-Urrutia A; Juárez-Rojas JG; Cardoso-Saldaña G; Jorge-Galarza E; Posadas-Sánchez R; Coyote-Estrada N; Nishimura-Meguro E; Posadas-Romero C
Pediatr Diabetes; 2013 Sep; 14(6):399-406. PubMed ID: 23057424
[TBL] [Abstract][Full Text] [Related]
77. Efficacy and Safety of Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in High-Risk and Low-Risk Patients with Type 2 Diabetes Stratified Using Common Clinical Performance Measures.
Lingvay I; Chao J; Dalal MR; Meneghini LF
Diabetes Technol Ther; 2017 May; 19(5):315-322. PubMed ID: 28467113
[TBL] [Abstract][Full Text] [Related]
78. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry.
Karter AJ; Ackerson LM; Darbinian JA; D'Agostino RB; Ferrara A; Liu J; Selby JV
Am J Med; 2001 Jul; 111(1):1-9. PubMed ID: 11448654
[TBL] [Abstract][Full Text] [Related]
79. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
[TBL] [Abstract][Full Text] [Related]
80. Beyond HbA1c: Comparing Glycemic Variability and Glycemic Indices in Predicting Hypoglycemia in Type 1 and Type 2 Diabetes.
Rama Chandran S; Tay WL; Lye WK; Lim LL; Ratnasingam J; Tan ATB; Gardner DSL
Diabetes Technol Ther; 2018 May; 20(5):353-362. PubMed ID: 29688755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
